zirconium has been researched along with oxyquinoline in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 7 (77.78) | 2.80 |
| Authors | Studies |
|---|---|
| Ballinger, JR; Blower, PJ; Charoenphun, P; Chuamsaamarkkee, K; Ferris, TJ; Meszaros, LK; Mullen, GE; Sharif-Paghaleh, E; Went, MJ | 1 |
| Asiedu, KO; Choyke, PL; Griffiths, GL; Sato, N; Szajek, LP; Wu, H | 1 |
| Liu, JJ; Liu, Y; Miao, LY; Pan, DH; Qi, W; Wang, GJ; Wang, LZ; Wang, XY; Wang, Y; Wu, Q; Xu, YP; Yan, JJ; Yang, M; Yu, L | 1 |
| Choyke, PL; Kurebayashi, Y; Sato, N | 1 |
| Carlsten, M; Friberger, I; Goos, JACM; Han, J; Harris, RA; Holmin, S; Jussing, E; Kaipe, H; Lambert, M; Samén, E; Siikanen, J; Tran, TA | 1 |
| Choyke, PL; Sato, N; Szajek, LP | 1 |
| Fang, Y; Lv, Y; Qin, T; Qiu, Y; Shao, Y; Wang, S; Wang, Y; Xu, B; Yan, H; Zheng, S | 1 |
| Harmošová, M; Kello, M; Potočňák, I; Samol'ová, E; Šebová, D; Smolko, L; Vilková, M | 1 |
| Astrelina, TA; Brunchukov, VA; Bubenshchikov, VB; Kobzeva, IV; Kodina, GE; Kulikova, LI; Larenkov, AA; Lunev, AS; Malsagova, KA; Nikitina, VA; Petrosova, KA; Pustovoyt, VI; Rastorgueva, AA; Samoilov, AS; Usupzhanova, DY | 1 |
1 review(s) available for zirconium and oxyquinoline
| Article | Year |
|---|---|
Imaging of cell-based therapy using
Topics: Animals; Humans; Mice; Oxyquinoline; Positron-Emission Tomography; Radioisotopes; Zirconium | 2021 |
8 other study(ies) available for zirconium and oxyquinoline
| Article | Year |
|---|---|
[(89)Zr]oxinate4 for long-term in vivo cell tracking by positron emission tomography.
Topics: Animals; Cell Line, Tumor; Humans; Mice; Mice, Inbred C57BL; Organometallic Compounds; Oxyquinoline; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Zirconium | 2015 |
(89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies.
Topics: Animals; Cell Tracking; Cell Transplantation; Cells; Isotopes; Mice; Mice, Inbred C57BL; Monitoring, Physiologic; Oxyquinoline; Positron-Emission Tomography; Zirconium | 2015 |
Feasibility study of
Topics: Animals; Burkitt Lymphoma; Cell Line, Tumor; Cell Tracking; Feasibility Studies; Gallium Radioisotopes; Humans; Immunotherapy, Adoptive; Oxyquinoline; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Receptors, Chimeric Antigen; T-Lymphocytes; Zirconium | 2021 |
Optimisation of the Synthesis and Cell Labelling Conditions for [
Topics: Animals; Cell Line, Tumor; Deferoxamine; Oxyquinoline; Positron-Emission Tomography; Radioisotopes; Rats; Tissue Distribution; Zirconium | 2021 |
Tracking of NK Cells by Positron Emission Tomography Using
Topics: Killer Cells, Natural; Oxyquinoline; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Zirconium | 2022 |
Biodistribution of 89Zr-oxine-labeled human bone marrow-derived mesenchymal stem cells by micro-PET/computed tomography imaging in Sprague-Dawley rats.
Topics: Animals; Bone Marrow; Humans; Mesenchymal Stem Cells; Oxalates; Oxyquinoline; Positron Emission Tomography Computed Tomography; Radioisotopes; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, X-Ray Computed; Zirconium | 2022 |
Low-dimensional compounds containing bioactive ligands. XXII. First crystal structure, cytotoxic activity and DNA and HSA binding of a zirconium(IV) complex with 8-hydroxyquinoline-2-carboxylic acid.
Topics: Coordination Complexes; Crystallography, X-Ray; Dimethylformamide; DNA; Humans; Hydrogen Bonding; Ligands; Oxyquinoline; Serum Albumin, Human; Zirconium | 2023 |
Biodistribution of Mesenchymal Stromal Cells Labeled with [
Topics: Animals; Animals, Laboratory; Cell Line, Tumor; Humans; Mesenchymal Stem Cells; Oxyquinoline; Positron-Emission Tomography; Radioisotopes; Rats; Tissue Distribution; Zirconium | 2023 |